Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels

Anticancer Res. 2003 Nov-Dec;23(6D):4953-8.

Abstract

Background: Angiogenesis plays important roles in pathogenesis in human cancer. We assessed the relationship between clinical features of renal cell cancer (RCC) and PlGF levels in relation to VEGF.

Materials and methods: Plasma PlGF and VEGF levels were measured in patients with renal cell cancer. The levels of these angiogenetic factors were analyzed in relation to clinical parameters.

Results: PlGF and VEGF levels in patients with RCC were significantly higher than those in non-cancer controls. PlGF levels were significantly associated with histological grade and total tumor vascularity (TTV), and VEGF levels were significantly associated with T, M stage, histological grade, venous invasion and TTV. Multivariate analysis showed plasma PlGF was an independent prognostic factor.

Conclusion: These findings suggested that plasma PlGF levels were significantly associated with the clinical features of RCC, especially prognostic significance.

MeSH terms

  • Carcinoma, Renal Cell / blood supply
  • Carcinoma, Renal Cell / blood*
  • Carcinoma, Renal Cell / pathology
  • Case-Control Studies
  • Female
  • Humans
  • Kidney Neoplasms / blood supply
  • Kidney Neoplasms / blood*
  • Kidney Neoplasms / pathology
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neovascularization, Pathologic / metabolism
  • Placenta Growth Factor
  • Pregnancy Proteins / blood*
  • Prognosis
  • Survival Rate
  • Vascular Endothelial Growth Factor A / blood*

Substances

  • PGF protein, human
  • Pregnancy Proteins
  • Vascular Endothelial Growth Factor A
  • Placenta Growth Factor